Haere mai ki te R1 News: Public Interest Journalism, funded through NZ On Air.
Tune in to R1 News weekdays at 1pm.
Haere mai ki te R1 News: Public Interest Journalism, funded through NZ On Air.
Tune in to R1 News weekdays at 1pm.
The National Institute of Health has just launched a phase one clinical trial evaluating three experimental HIV vaccines based on a messenger RNA technology.
The new HIV vaccine is set to follow the same guidelines and science as the Covid-19 vaccine.
Sunaina Born spoke to Professor Kurt Krause, a virologist at the University of Otago, who is currently looking into HIV research.